Amylin Pharmaceuticals Inc. (AMLN)

[SeriousMoney]

Amylin Pharmaceuticals to Present at Citigroup Healthcare Conference
INVESTMENT BANKING HEALTH-CARE CONFERENCES
PharmaLive, February 22, 2006

SAN DIEGO, February 22, 2006 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. will be presenting at the Citigroup Healthcare Conference on Tuesday, February 28, 2006 at 8:35 a.m. ET in Washington, DC. Mark Foletta, VP, Finance and Chief Financial Officer of Amylin Pharmaceuticals, will be providing a corporate overview.

The live presentation will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate website, located at http://www.amylin.com/ . To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development and commercialization of innovative, cost-effective medicines.

CONTACT: Alice Bahner, Executive Director, Investor Relations of AmylinPharmaceuticals, Inc., [phone]

Web site: http://www.amylin.com/
Ticker Symbol: (NASDAQ-NMS:AMLN)

http://www.pharmalive.com/News/index.cfm?articleid=317292&categoryid=62